FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Catheter, Coronary, Atherectomy

PMA: P130005 · Supplement: S049 · Decision Feb 18, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P130005 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Catheter, Coronary, Atherectomy
Trade Name
DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM
PMA Number
P130005
Supplement Number
S049
Device Class
FDA Class 3
Product Code
MCX
Generic Name
CATHETER, CORONARY, ATHERECTOMY
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
February 18, 2026
Date Received
January 22, 2026
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

implementing duplicate overmold equipment and updating the equipment parameters for the Diamondback 360 and Diamondback 360 Precision Coronary Orbital Atherectomy Device (OAD)

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MCX Catheter, Coronary, Atherectomy